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Abstract
Objectives
Our aim was to compare neuropsychological and psychiatric outcomes across three
encephalitis aetiological groups: Herpes simplex virus (HSV), other infections or autoim-
mune causes (Other), and encephalitis of unknown cause (Unknown).
Methods
Patients recruited from NHS hospitals underwent neuropsychological and psychiatric
assessment in the short-term (4 months post-discharge), medium-term (9–12 months after
the first assessment), and long-term (>1-year). Healthy control subjects were recruited from
the general population and completed the same assessments.
Results
Patients with HSV were most severely impaired on anterograde and retrograde memory
tasks. In the short-term, they also showed executive, IQ, and naming deficits, which
resolved in the long-term. Patients with Other or Unknown causes of encephalitis showed
moderate memory impairments, but no significant impairment on executive tests. Memory
impairment was associated with hippocampal/medial temporal damage on magnetic reso-
nance imaging (MRI), and naming impairment with left temporal and left frontal abnormali-
ties. Patients reported more subjective cognitive complaints than healthy controls, with
tiredness a significant problem, and there were high rates of depression and anxiety in the
HSV and the Other encephalitis groups. These subjective, self-reported complaints,
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depression, and anxiety persisted even after objectively measured neuropsychological per-
formance had improved.
Conclusions
Neuropsychological and psychiatric outcomes after encephalitis vary according to aetiology.
Memory and naming are severely affected in HSV, and less so in other forms. Neuropsycho-
logical functioning improves over time, particularly in those with more severe short-term
impairments, but subjective cognitive complaints, depression, and anxiety persist, and
should be addressed in rehabilitation programmes.
Introduction
Encephalitis–which refers to inflammation of the brain caused by infection or autoimmune
disease–can have debilitating long-term consequences [1]. Infectious causes, in particular her-
pes simplex virus (HSV), have long been considered the main cause of encephalitis [2,3]. The
relatively recent discovery of cell-surface antibodies has enabled a broadening of the search for
aetiologies of encephalitis. This has allowed the accurate diagnosis of an increasing number of
patients with autoimmune encephalitis [4,5], including those involving the n-methyl-d-aspar-
tate (NMDA) receptor [6] and the leucine-rich glioma 1 (LGI-1) protein [7]. However in 30–
50% of encephalitis patients, the aetiology still remains unknown, despite intensive investiga-
tions [2,3,8,9].
There have been few studies comparing neuropsychological outcomes across different
encephalitis aetiologies. Before the identification of cell-surface antibodies, several studies
were published on outcomes in patients recovering from HSV encephalitis [10–12]. Compared
with other infectious aetiologies, Hokkanen et al. [13] found that HSV patients showed greater
difficulty on verbal memory, semantic, and visuo-spatial functions than the other aetiological
groups. Studies focusing specifically on infectious causes of encephalitis other than HSV found
impairments in executive function [14], retrograde memory [13], visuo-spatial processing
[15], and working memory [16]. Pewter et al. [17] compared HSV and ‘non-HSV’ patients,
who included infectious and autoimmune aetiologies. They found significant and widespread
cognitive deficits in HSV patients, whereas ‘non-HSV’ patients showed more isolated disorders
of executive function [17]. Research focusing on autoimmune aetiologies indicates neuropsy-
chological impairments in attention, executive function, working memory, visuospatial and
language abilities, and memory [18–21]. However, these various studies did not use uniform
neuropsychological assessments to measure outcome, nor did they investigate how outcomes
related to patients’ self-reported perception of their cognitive abilities, depression, or anxiety.
In most cases, they also did not examine changes in outcomes over time.
In terms of neuroimaging, HSV encephalitis causes persisting hyper-intensities on
T2-weighted MRI scans and substantial volume loss in the medial temporal lobes [10,22]. Lat-
eral temporal and widespread cortical damage is also common [10,22,23]. The severity of
anterograde amnesia after HSV encephalitis appears to be correlated with the extent of pathol-
ogy in the medial temporal regions, with bilateral damage predictive of severe amnesia [10,11].
Limbic encephalitis with autoimmune aetiologies has been specifically associated with hippo-
campal atrophy, which is reported to correlate with disease severity and memory deficits [22–
24].
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In this study, we have investigated (i) neuropsychological outcomes; (ii) patients’ percep-
tions of their cognition, and (iii) psychiatric outcomes in terms of depression and anxiety at
three time-points after hospital discharge. We examined how this was related to clinical vari-
ables and neuroimaging findings. The study was a component of a NIHR programme grant on
encephalitis (ENCEPH-UK, www.encephuk.org), examining predictors of outcome [25,26].
Aims
The purpose of the current study was to examine:
1. The presence of distinct patterns of neuropsychological impairment across different sub-
groups of encephalitis patients, e.g. whether memory impairments were more evident in
specific diagnostic subgroups, whether executive function impairments were more pro-
nounced in other causes of encephalitis, and whether there were differences in IQ and
naming;
2. The patients’ perceptions of the impact of encephalitis on their lives, with respect to subjec-
tive, self-reported cognitive complaints, depression and anxiety;
3. The changes in neuropsychological performance across encephalitis subgroups when mea-
sured at different time-points; and
4. The relationship between clinical variables, neuroimaging, and neuropsychological/psychi-
atric outcomes.
Methods
Two cohorts of encephalitis patients were recruited and investigated between 2012 and 2015.
The first cohort was assessed 4 months after their hospital discharge to measure ‘short-term’
outcomes, and then again 9–12 months after the first assessment to examine ‘medium-term’
outcomes. This will be referred to as the “short- and medium-term outcome cohort”. The sec-
ond cohort was recruited at least 1 year after hospital discharge in order to examine the ‘long-
term’ outcomes. This will be referred to as the “long-term outcome cohort”. In both cohorts,
patients with current or prior neurological conditions or brain injuries impacting on cognitive
function were excluded in order to ascertain the specific association between neuropsychologi-
cal impairment and encephalitis. Migraine was not an exclusion criterion. A healthy control
group without neurological or psychiatric illness, subsequently referred to as “healthy con-
trols” or “healthy control group”, was recruited from the public. Fig 1 shows the recruitment
details of both patient cohorts as well as the healthy control group. The study received ethical
approval by the NRES Committee East Midlands–Nottingham 1 REC (ref 11/EM/0442). Writ-
ten informed consent was obtained from all participants.
For the main analyses, patients in each cohort were categorised into three diagnostic
groups: (i) HSV encephalitis (referred to as ‘HSV’), (ii) Encephalitis of Other Identified Causes
(referred to as ‘Other’), and (iii) Encephalitis of Unknown Cause (referred to as ‘Unknown’).
This was done according to predetermined case definitions for HSV and other infectious
causes [25–27] and autoimmune encephalitis [28]. Medical notes and discharge letters were
additionally reviewed by the study’s panel of infectious disease and neurology specialists.
For further exploratory analyses, the Other group was split into two subgroups: encephalitis
resulting from non-HSV infection (referred to as ‘Infections’) and autoimmune encephalitis
(referred to as ‘Autoimmune’).
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Participants
Short- and medium-term outcome cohort. Patients in the short- and medium-term out-
come cohort were identified by research nurses on hospital wards at ENCEPH UK sites. Forty-
five participants with encephalitis were recruited and assessed approximately 4 months after
hospital discharge (4.3±1.9 months) to assess short-term outcomes. When available, they were
assessed again 9–12 months after the first assessment (N = 28, 10.5±1.9 months) for medium-
term outcomes. There were 20 patients included in the HSV group, 10 patients in the Other
group, and 15 patients in the Unknown group. Table 1 shows the means, standard deviations
and frequencies for age, gender and Glasgow Coma Scale (GCS) scores at admission across
these three diagnostic groups.
As mentioned above, the Other group was split into two subgroups for further exploratory
analyses. In the short- and medium-term cohort, the Other group thus comprised 4 ‘Infec-
tions’ patients and 6 ‘Autoimmune’ patients.
Long-term outcome cohort. Patients in the long-term outcome cohort were identified by
consultants across ENCEPH UK hospital sites, from the Public Health England study database
[2] or they self-referred in response to a notice by the Encephalitis Society [27]. There were 81
Fig 1. Flowchart to outline the details of the recruitment process of patients with encephalitis into the short- and medium-term and long-term outcome cohorts,
and of healthy controls.
https://doi.org/10.1371/journal.pone.0230436.g001
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encephalitis patients, consisting of (i) 30 HSV patients, (ii) 24 Other patients, and (iii) 27
Unknown patients (see Table 1 for the means, standard deviations and frequencies of age and
gender).
For further exploratory analyses, the Other group in this long-term outcome cohort com-
prised 10 ‘Infections’ patients and 14 ‘Autoimmune’ patients.
Healthy controls. Healthy controls without neurological or psychiatric history were
recruited via community and website advertisements. From responders to these advertise-
ments, we recruited and assessed a total of 78 participants. Based on whole-group demo-
graphic variables (mean age, gender distribution, and mean premorbid IQ), 45 healthy
controls were matched to the short- and medium-term outcome cohort and 70 healthy con-
trols were matched to the long-term outcome cohort. Table 1 shows the means, standard devi-
ations and frequencies for age and gender in each matched healthy control group.
Materials
Well-validated neuropsychological tests were used to assess a range of neuropsychological
functions:
Intelligence (IQ): Premorbid: Wechsler Test of Adult Reading: WTAR [29]; Current: Wechs-
ler Abbreviated Scale of Intelligence, 2nd edition: WASI-II [30].
Anterograde memory: Doors and People battery [31], including verbal and visual, recall and
recognition tests.
Retrograde memory: Autobiographical Memory Interview [AMI, [32]], assessing personal
semantic and autobiographical incidents memory in terms of total scores.
Executive function: Verbal fluency: FAS [33]; executive control: Trail Making Test [34];
response initiation/suppression speed: Hayling Test; rule detection: Brixton Test [35].
Language: naming: Graded Naming Test [36]; semantic access from pictures: Pyramids and
Palm Trees: PPT [37].
Perception: Visual Object and Space Perception (VOSP) battery [38]; Benton Facial Recog-
nition test [39].
Subjective self-report measures were used to assess psychiatric outcomes in terms of depres-
sion and anxiety, and self-perceived cognitive complaints:
Psychiatric measures: Beck Depression Inventory: BDI [40]; Beck Anxiety Inventory: BAI
[41];
Table 1. Demographic characteristics of patients and controls in the short- and medium-term outcome cohort as well as patients and controls in the long-term out-
come cohort.
HSV Encephalitis
(n = 20)
Encephalitis of Other named cause
(n = 10)
Encephalitis of Unknown cause
(n = 15)
Healthy Controls
(n = 45)
Test
statistic
p-value
Short- and medium-term outcome cohort
Age, years (SD) 53.05 (13.93) 46.00 (16.73) 53.40 (13.51) 51.16 (16.82) F = 0.55 0.648
Male, n (%) 11 (55%) 3 (30%) 8 (53%) 23 (51%) X2 = 1.89 0.596
GCS at
admission
13.53 (1.46) 13.63 (1.41) 13.00 (2.45) - F = 0.41 0.667
Long-term outcome cohort
Age, years (SD) 48.37 (13.80) 46.50 (17.93) 50.00 (12.56) 50.80 (16.91) F = 0.506 0.679
Male, n (%) 10 (33%) 12 (50%) 11 (41%) 32 (46%) X2 = 1.89 0.596
The means (SD) and frequencies of demographic characteristics of the participants in this study. Statistical analyses reported here include ANOVA (F) and Chi-Squared
Test of Independence (X2). GCS score at admission was not available for the long-term outcome cohort. Abbreviations: SD (Standard Deviation), GCS (Glasgow Coma
Scale).
https://doi.org/10.1371/journal.pone.0230436.t001
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Self-perceived cognitive complaints: The A-B Neuropsychological Assessment (self-report)
Schedule: ABNAS [42] which examines tiredness, mental speed, memory, concentration,
motor skills, and language.
Information on clinical variables was also collected in the short- and medium-term out-
come cohort:
Time between hospital admission and commencement of appropriate drug treatment (anti-
viral, immunosuppressant), duration of hospital stay, and time between hospital admission
and neuropsychological testing. This information was not consistently available in the (retro-
spectively collected) long-term outcome cohort.
Procedure
Neuropsychological testing was conducted at the participant’s home or one of the research
sites (King’s College London, or Walton Centre, Liverpool).
The same battery of neuropsychological tests was used in the short- and medium-term out-
come cohort as well as the long-term outcome cohort.
Imaging
In the short- and medium-term outcome cohort, MRI scans were obtained during the course
of clinical care [27]; the scan closest in date to the first neuropsychological assessment was
analysed.
MRI analysis involved a qualitative, systematic assessment by two neuroradiologists. They
knew the patients had encephalitis but were blinded to aetiology and neuropsychological test
results. The brain was evaluated in pre-specified regions-of-interest: hippocampi (head, body
and tail), amygdalae, para-hippocampal gyri, occipito-temporal gyri, lateral temporal lobes
(temporal stem, superior, middle and inferior temporal gyri), insulae, cingulate gyri, fornices,
mammillary bodies, and frontal lobes (inferior and dorsolateral areas). These regions were
examined for oedema (signal change on T2-weighted or fluid-attenuated inversion recovery
[FLAIR] images), parenchymal loss (including cystic encephalomalacia), or gliosis. We focused
on the site of damage, rather than its nature (inflammatory change, signal alteration, volume
loss), and we determined whether ‘damage’ was present or absent at each anatomical location.
The inter-rater reliability between the two neuroradiologists was assessed using a Kappa coeffi-
cient score on this binary evaluation (presence/absence of damage) across all brain regions.
Statistical analysis
Shapiro-Wilk tests were used to assess for normality. One-way ANOVAs (parametric) or
Kruskal-Wallis tests (non-parametric) were conducted. ANCOVAs were used when neuropsy-
chological scores correlated significantly with either BDI or BAI. For parametric data, Hoch-
berg GT2 (homogeneity assumed) or Games-Howell (homogeneity not assumed) post-hoc
tests were applied to compare performance in individual encephalitis groups with that of
healthy controls. For non-parametric data, Mann-Whitney U tests were used for pairwise
comparisons; here, a corrected alpha of p = 0.02 was applied. In the short- and medium-term
outcome cohort, Spearman correlations were used to analyse associations between clinical and
neuropsychological variables, and where these were significant, linear regression analyses were
conducted, which included age and premorbid IQ as confounding variables. To increase the
sample size, all patients were merged into one group for correlation and regression analyses.
As described above, the Other group in both cohorts was subdivided into other Infections
and Autoimmune aetiological subgroups. Thus, for the further exploratory analyses there were
a total of four patient groups in each cohort: HSV, Infections, Autoimmune, and Unknown.
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Each of these four patient groups per cohort was compared with its own healthy control
group, matched for mean age, gender distribution, and mean premorbid IQ. T-tests or Mann-
Whitney U comparisons were then employed to identify specific neuropsychological impair-
ments within these aetiologies.
Rate of change between short- and medium-term timepoints was analysed by conducting
one-way ANOVAs or Kruskal-Wallis tests on difference scores. These analyses were con-
ducted only in the 28 participants who were assessed at both timepoints. Those lost to follow-
up were not included.
In the short- and medium-term outcome cohort, imaging (damage/no damage) compari-
sons between groups were analysed using chi-square test of independence, and associations
between imaging and neuropsychological findings were examined using point-biserial correla-
tions. Where correlations were significant, linear regression analyses were conducted and
included age and premorbid IQ as confounding variables.
Results
Short- and medium-term outcome cohort
To examine short-term outcomes, 45 patients were assessed and compared with 45 healthy
controls (see Table 1 for demographic characteristics and Table 2 for neuropsychological/psy-
chiatric outcome means and standard deviations). The recruitment flowchart outlines the spe-
cific aetiologies within each patient group (Fig 1).
For further exploratory analyses the Other group was split into two subgroups. The 4 ‘Infec-
tions’ patients comprised 2 males and 2 females and had a mean age of 59.90 (SD = 8.81). The
6 ‘Autoimmune’ patients comprised 1 male and 5 females and had mean age of 37.00
(SD = 14.64).
Intelligence
There was a lower mean full-scale IQ (FSIQ) in the HSV and Other groups compared with
healthy controls [F(3, 74) = 3.41, p = 0.02; post-hocs p<0.01 and p<0.05, respectively]. Verbal
IQ (VIQ) also differed across groups [F(3, 74) = 3.83, p = 0.01] with impairment in the Other
group (post-hoc p = 0.02). Performance IQ (PIQ) did not differ across groups (p = 0.23).
Anterograde memory
Fig 2(A) shows performance on verbal and visual, recall and recognition memory. There were
significant differences on visual recall [H(3) = 14.05, p = 0.003] and visual recognition memory
[F(3, 83) = 5.54, p = 0.002], with significant impairments in HSV versus healthy controls on
post-hoc testing (p<0.01).
Retrograde memory
Personal semantic memory [H(3) = 23.46, p<0.001] and autobiographical incidents memory
[H(3) = 23.81, p<0.001] differed across the groups (Table 2) with striking impairments in the
HSV group on both components (p<0.001), and in the Other group on autobiographical inci-
dents (p<0.001).
Executive function
Verbal fluency was impaired in HSV [H(3) = 10.91, p = 0.01; post-hoc p<0.01]. There were sig-
nificant group effects on response suppression speed [H(3) = 10.52, p = 0.02] and accuracy [H
(3) = 9.12, p = 0.03], resulting from impairment in the HSV group (post-hoc p’s�0.01).
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Language & visual semantic access
On Graded Naming, the HSV group showed severe impairment [F(3, 85) = 6.93, p<0.001;
post-hoc versus healthy controls, p<0.01]. On visual semantic access, all mean scores were in
the normal range.
Perception
All patient groups scored within the non-impaired range and Kruskal-Wallis and ANOVA
analyses did not reveal significant differences (p’s>0.19, Table 2).
Table 2. Short-term neuropsychological and psychiatric assessment scores in the short- and medium-term outcome cohort.
HSV (n = 20) Other (n = 10) Unknown
(n = 15)
Healthy Controls
(n = 45)
Test
statistic
p-value
Intelligence (WASI) Fullscale IQ 93.61 (12.86)
��†
90.90 (12.05)
�†
106.60 (17.25) 105.87 (11.98) F = 3.41 ♦□ 0.020
Verbal IQ 94.25 (12.95) 88.13 (11.48)
�■
103.07 (17.37) 105.14 (11.25) F = 3.83 ♦□ 0.010
Performance IQ 96.19 (13.29) 95.50 (13.25) 108.36 (17.64) 105.95 (13.96) F = 1.47 ♦ 0.230
Retrograde memory
(AMI)
Personal semantic 50.29 (6.93)
��^
57.44 (4.44) 55.92 (7.21) 59.27 (4.18) H = 23.46 <0.001
Autobiographical incidents 16.97 (5.70)
��^
17.56 (4.50)
��^
19.12 (8.02) 23.32 (2.71) H = 23.81 <0.001
Executive function Verbal fluency ⁰ (FAS) 38.11 (14.90)
��†
48.40 (9.18) 48.71 (24.38) 50.95 (13.08) H = 10.91 0.010
Executive Control ⁰ (Trails A-B) 74.21 (89.51) 42.53 (24.20) 39.43 (40.58) 39.64 (27.06) H = 2.83 0.420
Response initiation speed (Hayling) 4.83 (1.38) 5.10 (1.20) 5.43 (1.22) 5.31 (1.08) H = 2.48 0.480
Response suppression speed
(Hayling)
4.44 (1.58) ��^ 5.00 (2.26) 4.86 (1.70) 5.64 (0.08) H = 10.52 0.020
Response suppression accuracy
(Hayling)
4.44 (2.15) ��^ 6.78 (0.97) 5.50 (2.82) 6.27 (1.86) H = 9.12 0.030
Rule detection (Brixton errors) 19.72 (8.09) 20.50 (9.76) 14.21 (6.62) 15.60 (7.20) F = 1.00 ♦ 0.320
Language & semantic
ability
Naming (Graded) 14.11 (6.90)
��†
16.10 (5.02) 20.80 (5.51) 20.27 (5.06) F = 6.93 <0.001
Visual semantic access ⁰ (PPT) 50.17 (1.54) 50.40 (3.06) 51.77 (0.44) 50.22 (1.68) H = 17.68 0.001
Perception Incomplete letters ⁰ (VOSP) 19.22 (1.17) 19.80 (0.42) 19.67 (0.62) 19.43 (0.66) H = 3.86 0.280
Object decision ⁰ (VOSP) 17.22 (3.00) 18.90 (0.99) 19.87 (0.52) 17.41 (1.96) H = 27.03 <0.001
Position discrimination ⁰ (VOSP) 19.33 (1.68) 19.60 (0.70) 19.93 (0.26) 19.68 (0.67) H = 2.93 0.400
Face recognition ⁰ (Benton) 45.33 (5.11) 47.80 (2.70) 47.07 (3.45) 49.07 (3.47) F = 1.63 ♦ 0.190
Psychiatric measures BDI 16.76 (12.41)
��^
12.3 (9.52)
��^
14.43 (10.91) 6.31 (5.89) H = 16.18 0.001
BAI 12.12 (12.51)^ 9.50 (11.53) 12.21 (10.51) �^ 4.83 (5.00) H = 9.18 0.030
The mean scores (standard deviations) of each patient group and the healthy control group for all neuropsychological assessments and psychiatric measures are shown
in this table. Alongside are the test statistics [Kruskal-Wallis test (H); One-way ANOVA (F); or ANCOVA (F)] and all main effect p-values. For significant main effects,
post-hoc tests were conducted for each patient group vs the control group and significant differences are indicated by � for p� 0.05 and �� for p� 0.01.
Notations: ⁰ all mean scores in non-impaired range
non-significant trend
† Hochberg GT2/Games-Howell post-hoc (parametric)
^ Mann Whitney U post-hoc (non-parametric) (alpha value p = 0.02)
■ Bonferroni-corrected pairwise analysis (ANCOVA post-hoc). ANCOVA covariates
♦ Beck Depression Inventory
□ Beck Anxiety Inventory. Abbreviations: WASI (Wechsler Abbreviated Scale of Intelligence), AMI (Autobiographical Memory Inventory), FAS (F-A-S verbal fluency
test), PPT (Pyramids & Palm Trees), VOSP (Visual Object and Space Perception), BDI (Beck’s Depression Inventory), BAI (Beck’s Anxiety Inventory)
https://doi.org/10.1371/journal.pone.0230436.t002
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Psychiatric measures
The HSV and Other groups reported raised levels of depression [H(3) = 16.18, p = 0.001; post-
hoc versus healthy controls p’s<0.01], and the Unknown group higher levels of anxiety than
healthy controls [H(3) = 9.18, p = 0.03; post-hoc p<0.05] (Table 2).
Patient-perceived (subjective) cognitive function
Fig 3(A) shows mean ratings for each group on the six ABNAS subscales. Patients reported sig-
nificantly more perceived tiredness [H(3) = 20.37, p<0.001], slower mental speed [H(3) =
Fig 2. Mean anterograde memory scores for each aetiological group (Doors & People test). The error bars represent the standard deviation of the mean score within
each group. (a) At the short-term assessment, a mean of 4 months post-discharge (in the short- and medium-term outcome cohort) and (b) at the long-term assessment, at
least 1 year post-discharge (in the long-term outcome cohort). Notations: �p�0.05, ��p�0.01; † Hochberg GT2/Games-Howell post hoc (parametric); ■Bonferroni-
corrected pairwise analysis (ANCOVA post hoc). ^ Mann Whitney U post hoc (non-parametric).
https://doi.org/10.1371/journal.pone.0230436.g002
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15.89, p = 0.001], and complaints of impairments in memory [H(3) = 16.05, p = 0.001], con-
centration [H(3) = 14.64, p = 0.002], and language [H(3) = 9.09, p = 0.03]. The HSV and
Unknown groups reported high rates of complaints on 4 of the 6 ABNAS subscales. Correla-
tions with objective test performance were generally weak and non-significant, with the excep-
tion of a significant correlation between ABNAS Memory and verbal recognition memory
(rho = -0.35, p = 0.002).
Rate of change between short- and medium-term outcome
To examine change between short- and medium-term outcomes, 28 of the 45 patients studied
in the short- and medium-term outcome cohort were reassessed 9–12 months after their first
assessment. Difference scores (T2-T1) indicating rate of change were compared across enceph-
alitis groups.
On VIQ, there was a significant group difference in change scores [F(2, 24) = 4.98,
p = 0.02]. The Other group (8.43±6.90) improved significantly more than the Unknown group
(-4.27±9.77), whose score declined. There were no other significant group effects in change
scores on cognitive measures (p’s>0.07), patient-perceived cognitive impairments (p’s>0.09),
or mood assessments (p’s>0.05).
We compared mean age, GCS score at hospital admission as an indicator of illness severity,
and aetiology in the participants who dropped out versus those who did not. T-tests revealed
no significant differences in age or admission GCS score (p’s > 0.60). A Fisher’s exact test
showed no significant differences in aetiology (p = 0.10). The reasons for drop-out most com-
monly cited by our participants were tiredness and physical illness.
Clinical correlations
Table 3 shows that the time between hospital admission and commencement of appropriate
treatment correlated negatively with measures of intelligence, retrograde and anterograde
memory, and executive function (i.e. longer time until treatment was associated with worse
performance). Older age was correlated with lower scores on naming (rho = -0.30), and more
errors on the Hayling test (rho = 0.44) (both p<0.05). Treatment was instigated earlier if the
GCS score was low (rho = 0.34, p<0.05). To further examine these correlations, we also carried
out linear regression analyses, including time until treatment, premorbid IQ and age as poten-
tial predictors of neuropsychological outcome. On inputting these variables, we obtained sig-
nificant overall regressions in predicting verbal IQ [R2 = .42, F(3, 37) = 8.95, p< .001], verbal
recall [R2 = .34, F(3, 37) = 6.28, p = .001] and rule detection [R2 = .42, F(3, 36) = 8.69, p<
.001] scores. However, of our specific predictors, only premorbid IQ (β = .60, p< .001; β = .54,
p = .001; β = -.54, p< .001, respectively) and age (for rule detection only: β = .34, p = .01) were
statistically significant. Time until appropriate treatment did not contribute significantly to the
regression.
Table 3 shows that length of hospital stay also correlated significantly with measures of
memory and executive function (i.e. longer stay associated with worse performance). On the
other hand, it correlated with fewer patient-perceived language and motor complaints. On lin-
ear regression, increased length of stay remained a significant predictor of reduced patient-
perceived language complaints when covarying for premorbid IQ and age (β = -.55, p< .001)
[R2 = .39, F(3, 34) = 7.36, p = .001].
Imaging. Table 4 summarises the imaging findings on clinical MRI scans obtained closest to
the time of the first neuropsychological assessment. The kappa coefficient score for inter-rater
reliability between the two individuals assessing the binary presence/absence of damage was
0.98. There were significant differences between the three patient groups for hippocampal
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damage (particularly on the left) and medial temporal damage; both were most common in
the HSV group. In contrast, dorsolateral frontal damage was most common in the Unknown
group, and there were significant differences in comparing the distribution of left or right
medial temporal versus dorsolateral frontal changes across groups (left, X2 = 19.21, p<0.001;
right X2 = 19.18, p<0.001).
Table 5 shows that left hippocampal and left medial temporal damage were correlated with
lower IQ; and hippocampal and medial temporal damage with lower visual recall memory as
well as with poorer response initiation and suppression. Right hippocampal, medial temporal,
Fig 3. Subjective cognitive complaints for each group (ABNAS subscale scores). The error bars represent the standard deviation of the mean score within each group.
(a) At the short-term assessment, a mean of 4 months post-discharge (in the short- and medium-term outcome cohort) and (b) at the long-term assessment, at least 1-year
post-discharge (in the long-term outcome cohort). Notations: For main analyses of subscales (all Kruskal Wallis), significance is labelled adjacent to the subscale name
along the x-axis, alpha p = 0.05, � p� 0.05, �� p� 0.01; For the breakdown of main analyses using Mann Whitney U post hoc, significance is labelled adjacent to data
points within the figure, corrected alpha p = 0.02, � p� 0.02, �� p� 0.01, ^ trending significance (p = 0.03); Abbreviations: ABNAS (A-B Neuropsychological Assessment
Schedule).
https://doi.org/10.1371/journal.pone.0230436.g003
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and lateral temporal damage were all correlated with poor visual recognition memory. There
were also significant correlations between left temporal or frontal damage and graded naming.
To explore these associations further, regression analyses accounting for premorbid IQ and
age revealed that left medial temporal damage significantly predicted verbal IQ [R2 = .56, F(3,
30) = 12.59, p< .001; β = -.26, p = .05], fullscale IQ [R2 = .57, F(3, 30) = 13.27, p< .001; β =
Table 3. The significant correlations between clinical variables and short-term neuropsychological assessment scores in the short- and medium-term outcome
cohort.
Time since admission (months) Time until treatment (days) Length of stay in hospital (days)
Assessment Statistic Assessment Statistic Assessment Statistic
Executive control (TMT A-B) 0.38� Verbal IQ -0.32� Visual recall -0.41��
Verbal recall -0.36� Response suppression accuracy -0.33�
Verbal recognition -0.47�� Executive control (TMT A-B) 0.36�
Rule detection -0.35� ABNAS motor impairment -0.33�
ABNAS language -0.42��
Only significant correlations as assessed by Spearman rho test are shown. All patients were combined to increase the sample size.
Notations
� p � 0.05
�� p � 0.01; Abbreviations: TMT (Trail Making Test), ABNAS (A-B Neuropsychological Assessment Schedule)
https://doi.org/10.1371/journal.pone.0230436.t003
Table 4. Prevalence (%) of damage across brain regions in each encephalitis group on MRI.
HSV Other Unknown χ2
Total patients 16 11 18
N scanned 14 9 14
% of scanned patients with damage
Hippocampi Left 78.6 55.6 28.6 7.06�
Right 71.4 55.6 35.7 3.61
Either 92.9 66.7 35.7 10.05��
Medial temporal lobes Left 78.6 66.7 35.7 5.59
Right 71.4 66.7 35.7 4.11
Either 92.9 77.8 42.9 8.70��
Lateral temporal lobes Left 35.7 33.3 21.4 0.76
Right 35.7 33.3 14.3 1.87
Either 71.4 44.4 28.6 5.23
Inferior frontal lobes Left 28.6 22.2 7.1 2.18
Right 21.4 33.3 14.3 1.17
Either 42.9 33.3 14.3 2.81
Dorsolateral frontal cortices Left 0.0 11.1 21.4 3.34
Right 0.0 11.1 14.3 2.06
Either 0.0 11.1 21.4 3.34
The percentages of patients with left-sided, right-sided or either-sided damage in hippocampi, medial temporal lobes, lateral temporal lobes, inferior frontal lobes, and
dorsolateral frontal cortices is shown. Chi-squared test of independence statistics are also shown. N was determined by the number of patients with scans made available
to the study researchers.
Notations
� p � 0.05
�� p � 0.01
https://doi.org/10.1371/journal.pone.0230436.t004
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-.25, p = .05] and naming deficits [R2 = .48, F(3, 31) = 9.51, p< .001; β = -.27, p = .05]. Right
hippocampal damage predicted lower visual recall memory [R2 = .28, F(3, 29) = 3.72, p = .02;
β = -.34, p = .04] and right medial temporal damage significantly predicted lower visual recall
memory [R2 = .32, F(3, 29) = 4.55, p = .01; β = -.41, p = .02] and lower visual recognition mem-
ory [R2 = .23, F(3, 30) = 2.93, p = .05; β = -.35, p = .04]. Finally, left lateral temporal damage sig-
nificantly predicted naming impairment [R2 = .50, F(3, 31) = 10.12, p< .001; β = -.30, p = .03].
Long-term outcome cohort
Eighty-one patients completed neuropsychological and psychiatric assessments more than one
year after acute encephalitis and were compared with the scores of 70 healthy controls matched
on age and premorbid IQ. Table 1 summarises the demographic characteristics across groups
and Table 6 shows the means and standard deviations of the neuropsychological and psychiat-
ric outcome measures.
For further exploratory analyses, within the Other group, there were 10 ‘Infections’ patients
comprising 5 males and 5 females with a mean age of 49.70 (SD = 16.17), and 14 ‘Autoim-
mune’ patients comprising 7 males and 7 females with a mean age of 44.21 (SD = 16.20).s
Intelligence
No significant group differences were found on current FSIQ, VIQ, or PIQ (p’s>0.13).
Anterograde memory
Fig 2(B) shows significant group effects on verbal recall [F(3, 143) = 4.79, p = 0.003], visual
recall [F(3, 128) = 3.36, p = 0.02], and verbal recognition memory [F(3, 143) = 3.41, p = 0.02]
with the HSV group severely impaired relative to healthy controls (post-hoc p’s<0.02). By con-
trast, there were no group differences on visual recognition memory (p = 0.10).
Retrograde memory
Personal semantic memory did not differ significantly across groups (p = 0.18, Table 6). There
was a significant group effect on autobiographical incidents memory [H(3) = 13.15, p = 0.004],
reflecting impaired HSV and Unknown performance relative to healthy controls (post-hoc
p<0.001 and p = 0.03, respectively).
Executive function
Table 6 shows all executive function scores were in the non-impaired range (p’s>0.11).
Language & visual semantic access
On Graded Naming, the groups differed significantly [F(3, 132) = 4.01, p = 0.009], but post-
hoc analyses showed only a non-significant trend in the HSV group (p = 0.06, Table 6).
On visual semantic access, all scores approached ceiling.
Perception. Performance approached ceiling on all perception measures (Table 6).
Psychiatric measures. There were higher levels of depression [H(3) = 26.01, p<0.001] and
anxiety [H(3) = 13.58, p = 0.004] in all patient groups, relative to healthy controls (post-hoc
p’s<0.04) (Table 6).
Patient-perceived (subjective) cognitive function. Patients reported more complaints
than healthy controls [Fig 3(B)] in terms of tiredness [H(3) = 15.88, p = 0.001], mental speed
[H(3) = 13.31, p = 0.004], and impairments in memory [H(3) = 20.58, p<0.001], concentration
[H(3) = 15.21, p = 0.002], motor ability [H(3) = 9.69, p = 0.02], and language [H(3) = 13.10,
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p = 0.004]. Fig 3(B) shows that the HSV group expressed significantly more complaints than
healthy controls across all domains (post-hoc p’s<0.01). The Unknown group also reported
more difficulty than healthy controls on memory, language, and tiredness (post-hoc p’s<0.01).
The Other group reported greater tiredness than healthy controls (post-hoc p = 0.03).
On comparing the Autoimmune patient group with its matched healthy control group,
there were more frequent complaints concerning mental speed (U = 24.00, p = 0.006), memory
(U = 31.50, p = 0.02), and concentration (U = 32.00, p = 0.02).
There were some weak but statistically significant correlations between subjective (ABNAS)
ratings and objective test performance: ABNAS Memory complaints correlated with
(impaired) verbal and visual recall and verbal recognition memory scores (rho = -0.17 to-0.29,
p<0.05), and ABNAS Language complaints with (lower) FAS scores (rho = -0.24, p = 0.005).
Table 6. Long-term neuropsychological and psychiatric assessment scores in the long-term outcome cohort.
HSV (n = 30) Other (n = 24) Unknown
(n = 27)
Healthy Controls
(n = 70)
Test
statistic
p-value
Intelligence (WASI) Fullscale IQ 105.07 (16.64) 108.82 (11.61) 102.74 (15.27) 108.24 (11.91) F = 1.39 0.25
Verbal IQ 101.48 (17.58) 103.35 (14.89) 100.00 (16.03) 106.71 (11.28) F = 1.90 0.13
Performance IQ 108.21 (18.71) 111.55 (11.43) 105.11 (19.29) 107.89 (14.17) F = 0.67 0.57
Retrograde Memory
(AMI)
Personal semantic 55.48 (7.24) 57.00 (5.51) 56.70 (6.37) 58.72 (4.20) H = 4.88 0.18
Autobiographical incidents 19.14 (5.45)
��^
20.90 (6.24) 20.63 (5.20) �^ 23.27 (2.65) H = 13.15 0.004
Executive function Verbal fluency⁰ (FAS) 49.90 (14.26) 48.84 (13.10) 47.04 (12.81) 54.01 (14.32) F = 2.03 0.11
Executive Control ⁰ (Trails A-B) 53.80 (48.46) 33.02 (29.44) 35.45 (28.50) 34.94 (24.73) H = 3.61 0.31
Response initiation speed⁰ (Hayling) 5.03 (1.75) 5.43 (1.20) 5.37 (1.04) 5.50 (0.96) H = 2.53 0.31
Response suppression speed⁰
(Hayling)
5.03 (1.56) 5.43 (1.27) 5.19 (1.21) 5.71 (0.75) H = 5.96 0.11
Response suppression accuracy⁰
(Hayling)
6.07 (2.07) 5.83 (2.69) 7.74 (2.40) 6.30 (1.81) H = 0.44 0.93
Rule detection⁰ (Brixton errors) 16.87 (7.60) 16.57 (10.06) 16.22 (7.68) 14.01 (6.57) H = 3.92 0.27
Language & semantic
ability
Naming (graded) 16.70 (7.73) ^ 21.96 (4.85) 19.48 (4.79) 20.66 (4.92) F = 4.01 □ 0.009
Visual semantic access⁰ (PPT) 50.17 (2.26) 51.39 (0.78) 51.52 (0.58) 50.19 (1.83) H = 23.42 <0.001
Perception Incomplete letters⁰ (VOSP) 19.54 (1.04) 19.32 (1.00) 19.78 (0.51) 19.38 (0.75) H = 8.22 0.04
Object decision⁰ (VOSP) 18.17 (2.24) 18.59 (1.56) 18.30 (1.88) 17.21 (2.00) H = 14.81 0.002
Position discrimination⁰ (VOSP) 19.31 (2.49) 19.86 (0.47) 19.48 (1.40) 19.68 (0.68) H = 1.96 0.58
Face recognition⁰ (Benton) 47.60 (4.17) 48.48 (4.23) 48.19 (2.29 48.74 (3.47) H = 2.54 0.47
Psychiatric measures BDI 13.81 (8.13)
��^
12.65 (12.15)
�^
12.20 (11.15) ��^ 5.48 (5.37) H = 26.01 <0.001
BAI 10.04 (9.51)
��^
10.00 (9.80)
��^
9.36 (9.38) �^ 4.36 (4.64) H = 13.58 0.004
The mean scores (standard deviations) of each patient group and the healthy control group for all neuropsychological assessments and psychiatric measures are shown
in this table. Alongside are the test statistics [Kruskal-Wallis test (H); One-way ANOVA (F); or ANCOVA (F)] and all main effect p-values. For significant main effects,
post-hoc tests were conducted for each patient group vs the healthy control group and significant differences are indicated by � for p� 0.05 and �� for p� 0.01.
Notations: ⁰ all mean scores in non-impaired range
^ non-significant trend (0.05<p<0.07)
† Hochberg GT2/Games-Howell post-hoc (parametric)
^ Mann Whitney U post-hoc (non-parametric) (alpha value p = 0.02)
■ Bonferroni-corrected pairwise analysis (ANCOVA post-hoc). ANCOVA covariates
♦ Beck Depression Inventory
□ Beck Anxiety Inventory. Abbreviations: WASI (Wechsler Abbreviated Scale of Intelligence), AMI (Autobiographical Memory Inventory), FAS (F-A-S verbal fluency
test), PPT (Pyramids & Palm Trees), VOSP (Visual Object and Space Perception), BDI (Beck’s Depression Inventory), BAI (Beck’s Anxiety Inventory)
https://doi.org/10.1371/journal.pone.0230436.t006
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Discussion
The current study investigated neuropsychological and psychiatric outcomes across three dif-
ferent encephalitis groups in the short-term (4 months post-discharge), medium-term (9-
12-months follow-up after first assessment), and the long-term (>1 year post-discharge). We
found that that neuropsychological and psychiatric outcomes after encephalitis varied accord-
ing to the aetiology. Memory and naming impairments were most severely affected the HSV
group, and this was associated with more severe medial temporal lobe damage on MRI. Across
groups, cognitive performance improved over time, but subjective cognitive complaints,
depression, and anxiety persisted. We will discuss these findings with respect to our original
aims in turn.
In line with our first aim, which was to examine neuropsychological profiles across enceph-
alitis aetiological groups, differential patterns of neuropsychological impairment were found
across the patient groups. In the short-term, both HSV and patients with Other or Unknown
causes of encephalitis were impaired on anterograde memory, but this was more severe in the
HSV group, consistent with previous findings [15,17]. The Other group was also impaired
across anterograde memory tests, statistically significant for verbal recognition memory. In
terms of autobiographical memory, HSV patients showed short-term (<1 year) impairments
in the recall of personal semantic facts, and short- and long-term impairments (>1 year) in
recalling autobiographical episodes. The Unknown aetiology group also showed long-term
impairment in recalling autobiographical memories. Other authors have also found mild/
moderate memory impairments in ‘non-HSV’ encephalitis patients [13,17].
With respect to other cognitive functions, we did not find more pronounced executive
impairment in either the Other or the Unknown groups than the HSV patients, contrary to
Pewter et al.’s [17] finding of isolated executive impairment in ‘non-HSV’ patients. In the
short-term, only the HSV group showed impairments on executive function, naming, and full-
scale IQ. The naming impairment occurred in the presence of normal verbal fluency (FAS)
and normal visual semantic access. In the short-term, both the Other and the Unknown
groups were unimpaired on executive function and naming, and only the Other group was
impaired on verbal and full-scale IQ. In the long-term, the HSV group showed only a trend
towards impairment on naming, but otherwise there were no long-term impairments across
the aetiological groups on executive, naming, or IQ tasks. In other words, executive function,
naming, and IQ impairments appeared to resolve after the first year.
With respect to our second aim, which was to assess the patients’ subjective, self-reported
perceptions of their cognitive abilities, there were differences in tiredness, mental speed, con-
centration, memory, and language in the encephalitis groups compared with the healthy con-
trols. These occurred both in the short- and long-term after the illness (Fig 3), with HSV the
most, and the Other group the least, severely affected. Tiredness was a particularly prominent
complaint, as has also been reported elsewhere [43]. With respect to psychiatric outcomes,
there were significantly higher short-term rates of depression in the HSV and Other groups,
and anxiety in the Unknown group, than in healthy controls. In the Unknown group, this anx-
iety might reflect the negative impact of receiving an uncertain diagnosis. In the long-term, all
patient groups continued to show raised levels of depression and anxiety. This is in line with
findings from another study which examined psychiatric sequelae of encephalitis, suggesting
depression and anxiety can arise both from neurobiological changes and from the psychologi-
cal adjustment to encephalitis [44]. It is notable that, in terms of patients’ subjective percep-
tions of cognitive function and mood state, complaints remained severe after the first year.
This appears particularly at odds with current and previous suggestions of improved objec-
tively measured cognitive function over time [45,46], and may reflect the dawning realisation
PLOS ONE Neuropsychological and psychiatric outcomes of encephalitis
PLOS ONE | https://doi.org/10.1371/journal.pone.0230436 March 25, 2020 16 / 24
that further improvement after severe neurological illness was likely to be slow and limited
[43,47–49]. Correlations between subjective complaints and objective performance were gen-
erally low.
The third aim was to examine the rate of change between the short (4 months)- and
medium-term (9–12 months later) post-discharge. Rates of change were broadly equivalent
across the patient groups during the first year, except that the Other group showed significant
improvement on verbal IQ, whereas the Unknown group showed a decline in verbal IQ. Dur-
ing this first year, the HSV group showed a widespread pattern of cognitive impairment
(memory, executive functioning, verbal IQ performance, and naming). After the first year,
these had narrowed down to a predominant deficit in anterograde and retrograde memory. In
the Other and Unknown cause groups, cognitive deficits which had been evident during the
first year were no longer present, except for the Unknown group’s performance on autobio-
graphical event memory.
Fourthly, we examined the relationship between clinical variables and short-term neuropsy-
chological and psychiatric outcomes. Time between admission and commencement of appro-
priate treatment, as well as a longer hospital stay, were both correlated with poorer memory
and executive outcomes, emphasizing the importance of timely treatment [2,21]. Timely treat-
ment may be particularly important in older adults and those with lower premorbid intellec-
tual abilities. Furthermore, despite the association with poorer memory and executive
outcome on objective assessments, longer hospital stay was also correlated with fewer self-
reported motor and language complaints, possibly because these had been more fully
addressed during a more extensive stay. In line with this, a longer hospital stay significantly
predicted lower self-reported language complaints even after accounting for age and premor-
bid IQ. It is possible that reducing self-reported complaints by providing thorough clinical
care may improve mood, which in turn might reduce complaints further [50] and enhance
objectively measured cognitive performance–this requires further investigation.
With regard to the MRI findings across all three patient groups, there were significant cor-
relations between short-term visual recall and recognition scores and the presence of hippo-
campal and medial temporal lobe pathology. Naming impairment was associated with the
presence of left-sided damage on MRI. Linear regression analyses accounting for premorbid
IQ and age revealed that hippocampal and temporal damage remained significant predictors,
directly supporting the relationship between brain lesion and short-term neuropsychological
impairments.
Study limitations
Even though the present study was multi-centre across UK-wide NHS departments, recruit-
ment to the Other group, particularly the autoimmune aetiologies was difficult. At the time of
recruitment, cell-surface antibodies aiding autoimmune diagnosis were not always consistently
being tested in hospitals. In this neuropsychological sub-study, HSV cases comprised 33.3% of
the short- and medium-term cohort, and 55% of the long-term cohort. The ENCEPH-UK par-
ent study comprised 20% of HSV cases, which is very similar with the 19% HSV cases recruited
in the HPA study [2]. The increased representation of HSV cases in the neuropsychological
sub-study may have resulted from a response bias since participants could opt in to take part
in the neuropsychological assessments if they wished. Overall, it is therefore important to state
that the diagnostic proportions reported here are not reflective of true prevalence rates, espe-
cially with recent advances in diagnostic tools for autoimmune encephalitis. Secondly, there
were relatively high rates of attrition between the initial assessment and the follow-up 9–12
months later. This could not be attributed to differences in aetiology, illness severity (based on
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GCS at admission) or age. In fact, the reasons for drop-out most commonly cited by our par-
ticipants were tiredness and physical illness, consistent with subjective complaints reported
across all three encephalitis subgroups. Finally, the patient participants in the short- and
medium-term outcome cohort were not the same individuals as in the long-term outcome
cohort. While this does not affect the interpretation of the findings within each cohort, it is
nonetheless worth noting that the ‘longitudinal’ conclusions of this study should be interpreted
cautiously.
Summary and conclusions
In summary, the HSV group was the most impaired, and memory was the most severely
affected cognitive function within this group. In the short- and medium-term assessments (4
months to 1-year post-discharge), the HSV group also showed deficits in executive function,
verbal IQ, and naming. In the long-term (>1 year), these deficits had narrowed down to
impaired anterograde and autobiographical memory. The Other and Unknown groups also
showed most impairment in memory relative to other neuropsychological functions, which is
contrary to some previous observations [17]. On subjective evaluations, the HSV group
reported self-perceived problems in memory, language, tiredness, concentration, and mental
speed, as well as depressed mood; and these were still present at>1 year. In the Other and
Unknown groups, there were also patient-perceived, subjective cognitive complaints, anxiety,
and depression, with tiredness being identified as a common problem. In particular, the Other
group reported high rates of depression, whereas the Unknown group described anxiety, possi-
bly indicating that receiving an uncertain diagnosis increases anxiety. In terms of associated
clinical factors, delayed time until appropriate treatment, and prolonged hospital stay, were
correlated with poorer outcomes across the patient groups, underlining the importance of
timely treatment [1].
These findings have implications for neuropsychological rehabilitation. Outcomes for
patients with encephalitis differed across the aetiological groups, and rehabilitation should be
tailored to this. It is important that psychiatric conditions including depression and anxiety
are treated appropriately as this may positively influence the success of neurorehabilitation for
cognitive deficits [44]. Compensatory strategies, aiming to capitalize on preserved executive
function, could be used to support memory [51], and self-perceived cognitive complaints,
fatigue, depression, and anxiety are particularly important to address.
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